A Simple Key For Healthcare News Unveiled
Novo CEO pressed by Senate to cut prices of being overweight, diabetic issues medication CEO Lars Fruergaard Jørgensen advised lawmakers the business would contemplate new talks with insurers with regard to the listing charges of Wegovy and copyright should they pledge to keep the medicines on their formularies.The deal should be concluded by Sept